A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

ClinicalTrials.gov ID: NCT00428220

Public ClinicalTrials.gov record NCT00428220. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment

Study identification

NCT ID: NCT00428220
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Pfizer; Industry
Enrollment: 223 participants

Conditions and interventions

Conditions

Interventions

sunitinib Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 30, 2007
Primary completion: Jul 31, 2014
Completion: Aug 31, 2014
Last update posted: Jun 26, 2019

2007 – 2014

United States locations

U.S. sites: 15
U.S. states: 8
U.S. cities: 10

Facility	City	State	ZIP	Site status
Emory University, Winship Cancer Institute	Atlanta	Georgia	30322	—
Investigational Drug Service	Atlanta	Georgia	30322	—
The Emory Clinic	Atlanta	Georgia	30322	—
Loyola University Medical Center	Maywood	Illinois	60153	—
University of Iowa Hospitals and Clinics	Iowa City	Iowa	52242	—
Siteman Cancer Center	City of Saint Peters	Missouri	63376	—
Siteman Cancer Center-West County	Creve Coeur	Missouri	63141	—
Barnes Jewish Hospital	St Louis	Missouri	63110	—
Washington University School of Medicine, Siteman Cancer Center	St Louis	Missouri	63110	—
Comprehensive Cancer Center of Nevada	Las Vegas	Nevada	89128	—
Comprehensive Cancer Centers of Nevada	Las Vegas	Nevada	89169	—
Northwest Cancer Specialists, P.C.	Portland	Oregon	97213-2982	—
Northwest Cancer Specialists, P.C.	Portland	Oregon	97225	—
US Oncology Research and Clinical Pharmacy (Drug Shipment Only)	Fort Worth	Texas	76177	—
The Strelitz Diabetes Institute of Eastern Virginia Medical School	Norfolk	Virginia	23510	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00428220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 26, 2019 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00428220 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →